• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

衰老对血压正常者及原发性高血压患者尿激肽释放酶排泄的影响。

The effect of aging on urinary kallikrein excretion in normotensive subjects and in patients with essential hypertension.

作者信息

Naka T, Ogihara T, Hata T, Maruyama A, Mikami H, Nakamaru M, Gotoh S, Masuo K, Ohde H, Iwanaga K, Kumahara Y

出版信息

J Clin Endocrinol Metab. 1981 May;52(5):1023-6. doi: 10.1210/jcem-52-5-1023.

DOI:10.1210/jcem-52-5-1023
PMID:6908897
Abstract

The effect of aging on urinary kallikrein excretion (UkalV) was investigated in 54 normal subjects, 11-88 yr old, and 37 patients with essential hypertension, 17-82 yr old. Urinary sodium, potassium, and aldosterone excretion (U(Ald)V) were also measured in these subjects. Urinary sodium and potassium excretion in both normal subjects and hypertensive patients did not significantly change with aging. In normal subjects, U(kal)V (r = 0.45; P less than 0.001) and U(Ald)V (r = 0.58; P less than 0.01) significantly decreased with increasing age. U(kal)V was positively correlated with U(Ald)V (r = 0.44; P less than 0.001). In contrast, the hypertensive patients had a significant decrease with age in U(Ald)V (r = -0.36; P less than 0.05), but no significant age-related change in U(kal)V. No significant correlation between U(kal)V and U(Ald)V was observed in the hypertensive patients. In individuals less than 60 yr old, there was no significant difference in U(kal)V values between normal subjects and hypertensive patients. Hypertensive patients more than 60 yr old excreted more urinary kallikrein than normal subjects of the same age group (P less than 0.05). In conclusion, the age-related decrease of U(kal)V in normal subjects may be due to the reduced activity of the renin-angiotensin-aldosterone system. It remains to be elucidated whether the absence of the age-related decrease in U(kal)V in hypertensive patients is related to the pathogenesis or pathophysiology of essential hypertension.

摘要

在54名年龄为11至88岁的正常受试者以及37名年龄为17至82岁的原发性高血压患者中,研究了衰老对尿激肽释放酶排泄量(UkalV)的影响。同时还测量了这些受试者的尿钠、钾和醛固酮排泄量(U(Ald)V)。正常受试者和高血压患者的尿钠和钾排泄量均未随衰老而发生显著变化。在正常受试者中,U(kal)V(r = 0.45;P < 0.001)和U(Ald)V(r = 0.58;P < 0.01)均随年龄增长而显著降低。U(kal)V与U(Ald)V呈正相关(r = 0.44;P < 0.001)。相比之下,高血压患者的U(Ald)V随年龄增长显著降低(r = -0.36;P < 0.05),但U(kal)V未出现与年龄相关的显著变化。在高血压患者中,未观察到U(kal)V与U(Ald)V之间存在显著相关性。在60岁以下的个体中,正常受试者和高血压患者的U(kal)V值无显著差异。60岁以上的高血压患者比同年龄组的正常受试者排泄更多的尿激肽释放酶(P < 0.05)。总之,正常受试者中U(kal)V随年龄增长而降低可能是由于肾素 - 血管紧张素 - 醛固酮系统活性降低所致。高血压患者中U(kal)V未出现与年龄相关的降低是否与原发性高血压的发病机制或病理生理学相关,仍有待阐明。

相似文献

1
The effect of aging on urinary kallikrein excretion in normotensive subjects and in patients with essential hypertension.衰老对血压正常者及原发性高血压患者尿激肽释放酶排泄的影响。
J Clin Endocrinol Metab. 1981 May;52(5):1023-6. doi: 10.1210/jcem-52-5-1023.
2
[Selected components of the kallikrein-kinin system and of the renin-angiotensin-aldosterone system in offspring of parents with hypertension].[高血压患者后代中激肽释放酶-激肽系统和肾素-血管紧张素-醛固酮系统的选定成分]
Ann Acad Med Stetin. 1996;42:123-38.
3
Urinary kallikrein in normotensive subjects and in patients with essential hypertension.正常血压受试者和原发性高血压患者的尿激肽释放酶
Clin Exp Hypertens (1978). 1980;2(3-4):693-708. doi: 10.3109/10641968009037137.
4
Effects of dietary potassium and race on urinary excretion of kallikrein and aldosterone in man.饮食钾和种族对人体尿激肽释放酶及醛固酮排泄的影响。
J Clin Endocrinol Metab. 1978 Aug;47(2):296-9. doi: 10.1210/jcem-47-2-296.
5
[The investigation about age-related changes in vasoactive substances of normal subjects and of patients with essential hypertension].
Nihon Jinzo Gakkai Shi. 1992 Mar;34(3):287-93.
6
Urinary kallikrein excretion in essential and mineralocorticoid hypertension.原发性高血压和盐皮质激素性高血压患者的尿激肽释放酶排泄情况。
J Clin Invest. 1980 Feb;65(2):347-56. doi: 10.1172/JCI109678.
7
[Correlations between circulation levels of natriuretic atrial peptide and urinary excretion of kallikrein in young normotensive and hypertensive subjects].[年轻血压正常和高血压受试者中利钠肽循环水平与激肽释放酶尿排泄之间的相关性]
Ann Ital Med Int. 1991 Apr-Jun;6(2):217-23.
8
Effect of furosemide on urinary kallikrein excretion in patients with essential hypertension.速尿对原发性高血压患者尿激肽释放酶排泄的影响。
Tohoku J Exp Med. 1978 Mar;124(3):197-203. doi: 10.1620/tjem.124.197.
9
Increased urinary kallikrein excretion in young borderline hypertensive patients.
Clin Exp Hypertens A. 1983;5(6):903-18. doi: 10.3109/10641968309081816.
10
Study on the renal kallikrein-kinin system in normal and low renin subgroups of essential hypertension.原发性高血压正常肾素亚组和低肾素亚组的肾激肽释放酶-激肽系统研究
J Hypertens Suppl. 1984 Dec;2(3):S297-9.

引用本文的文献

1
Changes in the renin-angiotensin-aldosterone axis in later life.老年期肾素-血管紧张素-醛固酮轴的变化
Drugs Aging. 1994 Nov;5(5):391-400. doi: 10.2165/00002512-199405050-00007.